Success Story: NIW Approval Secured for an Organic Chemistry Researcher From India
Client’s Testimonial:
"I am very pleased with the outstanding service provided by WeGreened/Chen’s team throughout my EB-2 NIW petition process. They were highly professional, thorough, and meticulous in preparing my petition, and consistently responsive to all my questions from beginning to end. I am truly grateful for their guidance and dedication in helping me secure a successful approval."
On June 25th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Compliance Specialist in the Field of Organic Chemistry (Approval Notice).
General Field: Organic Chemistry
Position at the Time of Case Filing: Senior Compliance Specialist
Country of Origin: India
State of Residence at the Time of Filing: New Hampshire
Approval Notice Date: June 25th, 2026
Processing Time: 6 months, 5 days (Premium Processing Upgrade Requested)
Case Summary:
Scientific advances in organic chemistry often provide the foundation for breakthroughs in medicine, particularly when they enable the development of better diagnostic tools, vaccines, and therapeutic technologies. In this approved EB-2 National Interest Waiver (NIW) case, the client demonstrated a sustained commitment to improving carbohydrate-based technologies that support the diagnosis and treatment of infectious diseases and other major health challenges. Through a carefully prepared petition, North America Immigration Law Group (NAILG) demonstrated both the national importance of the client's research and why the client was well positioned to continue making valuable contributions in the United States.
The client earned a Ph.D. in Organic Chemistry and, at the time of filing, was employed as a senior compliance specialist while continuing research in the field. The client's long-term research focuses on developing innovative technologies for the rapid synthesis of carbohydrate glycoconjugates to address critical challenges in pathogen diagnostics, vaccine development, and advanced therapeutic solutions. The petition explained that these technologies have applications extending beyond laboratory research by supporting improved diagnostic capabilities, accelerating vaccine development, and advancing therapeutic strategies that address important public health needs.
A central aspect of the petition involved demonstrating that the client had already established a meaningful record of achievement that indicated the ability to continue advancing this work. Rather than relying on publication numbers alone, we explained how the client's scholarly accomplishments reflected growing recognition from the scientific community. The petition highlighted the client's:
- 15 peer-reviewed journal articles (including 6 first-authored publications), 4 conference abstracts, 2 book chapters, and 1 patent;
- 825 citations;
- Completion of at least 18 peer reviews.
We further showed that these accomplishments reflected independent reliance on the client's research rather than simple publication activity. The citation record demonstrated that other researchers had incorporated the client's findings into their own work, while invitations to review manuscripts illustrated professional confidence in the client's scientific judgment. In addition, evidence showing support from the Bill & Melinda Gates Foundation, the National Institute of General Medical Sciences, and the Natural Sciences and Engineering Research Council of Canada further reinforced that the client's research addressed objectives recognized as important by leading research funding organizations. Together, these factors helped establish that the client was well positioned to continue advancing research with broad scientific and practical significance.
The petition also included 2 expert recommendation letters that provided independent evaluations of the client's research accomplishments and future potential. These letters explained how the client's innovations contributed to the advancement of carbohydrate chemistry and highlighted the broader value of this work for improving pathogen diagnostics, vaccine development, and therapeutic technologies.
“Ensuring that [Client’s] work proceeds is thus not only important to the field, but to the United States as well.”
By presenting a comprehensive record that connected the client's research achievements, scholarly recognition, funding history, and future research plans, NAILG demonstrated that the client satisfied the requirements for a National Interest Waiver. The approval reflects how a carefully documented record can establish not only past scientific contributions, but also the applicant's continued ability to advance research that serves important national interests.